date:May 26, 2012
EFSAs Panel on Dietetic Products, Nutrition and Allergies (NDA) said there were no safety issues in a range of matrices including food supplements, infant and follow-on formulae, dietetic food for special medical purposes and sports nutrition, and for foods such as non-alcoholic beverages, cakes and pastries, products derived from cheese, milk-based products, cold snacks and sweets.
After assessing animal and in vitro data, the NDA found no safety issues at proposed intakes ranging from 667mg/1